[Federal Register Volume 88, Number 165 (Monday, August 28, 2023)]
[Notices]
[Page 58544]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-18466]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-30-2023]


Foreign-Trade Zone (FTZ) 7; Authorization of Production Activity; 
AbbVie Ltd.; (Pharmaceutical Products); Barceloneta, Puerto Rico

    On April 25, 2023, AbbVie Ltd., submitted a notification of 
proposed production activity to the FTZ Board for its facility within 
Subzone 7I, in Barceloneta, Puerto Rico.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (88 FR 27860--27861, May 3, 2023). On 
August 23, 2023, the applicant was notified of the FTZ Board's decision 
that no further review of the activity is warranted at this time. The 
production activity described in the notification was authorized, 
subject to the FTZ Act and the FTZ Board's regulations, including 
section 400.14.

    Dated: August 23, 2023.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2023-18466 Filed 8-25-23; 8:45 am]
BILLING CODE 3510-DS-P